Chugai Pharmaceutical Co Ltd (CHGCY)
20.30
-0.39
(-1.88%)
USD |
OTCM |
Nov 22, 16:00
Chugai Pharmaceutical Enterprise Value: 61.74B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 61.74B |
| November 21, 2024 | 63.02B |
| November 20, 2024 | 62.33B |
| November 19, 2024 | 63.25B |
| November 18, 2024 | 63.88B |
| November 15, 2024 | 70.20B |
| November 14, 2024 | 70.26B |
| November 13, 2024 | 70.69B |
| November 12, 2024 | 72.44B |
| November 11, 2024 | 74.08B |
| November 08, 2024 | 72.47B |
| November 07, 2024 | 71.22B |
| November 06, 2024 | 71.74B |
| November 05, 2024 | 71.81B |
| November 04, 2024 | 73.19B |
| November 01, 2024 | 72.96B |
| October 31, 2024 | 73.36B |
| October 30, 2024 | 73.59B |
| October 29, 2024 | 76.98B |
| October 28, 2024 | 79.08B |
| October 25, 2024 | 72.60B |
| October 24, 2024 | 70.07B |
| October 23, 2024 | 68.96B |
| October 22, 2024 | 69.90B |
| October 21, 2024 | 71.28B |
| Date | Value |
|---|---|
| October 18, 2024 | 72.73B |
| October 17, 2024 | 72.60B |
| October 16, 2024 | 73.82B |
| October 15, 2024 | 76.40B |
| October 14, 2024 | 75.53B |
| October 11, 2024 | 74.31B |
| October 10, 2024 | 71.91B |
| October 09, 2024 | 72.53B |
| October 08, 2024 | 71.71B |
| October 07, 2024 | 71.09B |
| October 04, 2024 | 72.70B |
| October 03, 2024 | 73.09B |
| October 02, 2024 | 73.13B |
| October 01, 2024 | 75.13B |
| September 30, 2024 | 74.21B |
| September 27, 2024 | 75.95B |
| September 26, 2024 | 76.58B |
| September 25, 2024 | 74.64B |
| September 24, 2024 | 75.69B |
| September 23, 2024 | 74.51B |
| September 20, 2024 | 73.75B |
| September 19, 2024 | 74.05B |
| September 18, 2024 | 72.83B |
| September 17, 2024 | 74.67B |
| September 16, 2024 | 73.52B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
33.72B
Minimum
Nov 09 2022
89.29B
Maximum
Jan 12 2021
54.80B
Average
53.82B
Median
Mar 27 2020
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 71.45B |
| Nxera Pharma Co Ltd | 818.86M |
| PeptiDream Inc | 2.175B |
| Healios KK | 90.57M |
| AnGes Inc | 86.92M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 737.17M |
| Revenue (Quarterly) | 2.125B |
| Total Expenses (Quarterly) | 1.045B |
| EPS Diluted (Quarterly) | 0.224 |
| Gross Profit Margin (Quarterly) | 73.32% |
| Profit Margin (Quarterly) | 34.69% |
| Earnings Yield | 3.85% |
| Operating Earnings Yield | 5.35% |
| Normalized Earnings Yield | 3.852 |